Tenax Therapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDTenax Therapeutics, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 87), indicating clear outperformance against the broad market. Earnings contraction of 111% provides fundamental context to the price action. Investors should exercise caution due to high volatility (69% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $13.84 | -13.15% | BELOW |
| 50 SMA | $13.79 | -12.86% | BELOW |
| 100 SMA | $13.43 | -10.53% | BELOW |
| 150 SMA | $11.56 | +3.95% | ABOVE |
| 200 SMA | $10.22 | +17.63% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TENX in an uptrend right now?
TENX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is TENX overbought or oversold?
TENX's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is TENX outperforming the market?
TENX has a Relative Strength (RS) Rating of 87 out of 99. Yes, TENX is a market leader, outperforming 87% of all stocks over the past 12 months.
Where is TENX in its 52-week range?
TENX is trading at $12.02, which is 65% of its 52-week high ($18.38) and 51% above its 52-week low ($5.34).
How volatile is TENX?
TENX has a Beta of 0.90 and 52-week volatility of 69%. It's less volatile than the S&P 500 - generally more stable.